Functional Brands 10-Q: $10.3M Nine-Month Loss, $231,900 Cash, Going Concern and Debt Defaults
MEHA sits 50% above its 52-week low of $0.002 on elevated volume (2.3× avg).
Summary
Functional Brands reported a $10.3 million nine-month net loss with just $231,900 of cash and repeated its going-concern warning. It remains in default on its Series C preferred and convertible notes after missing the June 8 mandatory redemption and losing its Nasdaq listing.
Key Events · Legal and Risk Events · MEHA
-
Nine-Month Loss Widens to $10.3M
Net loss for the nine months ended September 30, 2026 was $10,335,792 versus $93,837 a year earlier, driven by a $6,310,464 loss on issuance of preferred stock and a $1,097,362 derivative remeasurement charge.
-
Cash Drops to $231,900
Cash fell from $2,726,696 at December 31, 2025 to $231,900, with a working capital deficit of $5,804,557 and an accumulated deficit of $17,394,167.
-
Defaults on Series C and Notes
Failure to begin the $230,333 monthly Series C redemption on June 8, 2026 and the June 16 delisting are events of default; the $2,764,000 Series C stated value and $993,525 of notes are current liabilities at 24% default interest and a 125% default premium.
-
Going Concern Doubt Unresolved
Management concluded substantial doubt about the ability to continue as a going concern within one year has not been alleviated and that no committed financing exists to cover the obligations.
Analysis · MEHA · Life Sciences
Cash of $231,900 stands against a $5.8 million working capital deficit and $2.76 million of Series C preferred that the company was required to start redeeming on June 8, 2026 but did not. That missed redemption, together with the June 16 Nasdaq delisting, constitutes events of default under both the Series C and the $993,525 of senior secured convertible notes, which are now current liabilities and accrue 24% default interest with a 125% default premium. Management states plainly that substantial doubt about going concern has not been alleviated and that no financing is committed. The only path shown is negotiating with holders or raising new equity or debt, and any share settlement at the 85%-of-lowest-price alternate conversion price would be heavily dilutive to the 64.9 million shares now outstanding.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 52.8% of the 195 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.69%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MEHA was trading at $0.00 on OTC in the Life Sciences sector, with a market capitalization of approximately $194.8K. The 52-week trading range was $0.00 to $0.51. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.